Laparoscopic Device Market

Laparoscopic Device Market Outlook from 2024 to 2034

FThe laparoscopic device market is anticipated to be worth USD 13.59 billion in 2024. Companies are using various tactics to deal with supply chain disruptions.

The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass USD 20.5 billion by 2034. The surge in the prevalence of obesity across all age groups is raising the market growth.

Attributes	Details
Laparoscopic Device Market Value for 2024	USD 13.59 billion
Laparoscopic Device Market Value for 2034	USD 20.5 billion
Laparoscopic Device Market Forecast CAGR for 2024 to 2034	4.2%

Key Highlights of the Laparoscopic Device Industry

• Advantages over open surgeries, like smaller incisions, less discomfort after surgery, shorter hospital stays, and quicker recovery times, laparoscopic treatments have become the procedure of choice for many surgeries.
• The need for laparoscopic surgeries is being driven by conditions like obesity, gastrointestinal issues, and different forms of cancer.
• Governments and the private healthcare sector are investing in healthcare infrastructure and technologies, including laparoscopic equipment to enhance patient outcomes and lower healthcare costs related to lengthier hospital stays and post-operative problems.

Historical Performance and Future Growth of the Laparoscopic Device Market

Historical CAGR	5.3%
Forecast CAGR	4.2%

The historical CAGR of the laparoscopic device market was 5.3%, indicating a moderate growth rate over the past few years. The forecast CAGR is expected to be 4.2%, indicating a slight yet steady fall in the growth rate through 2034.

• Growth in disposable incomes, better healthcare infrastructure, and boost in knowledge of less invasive surgical procedures are contributing to the laparoscopic device market economies.
• A rise in emphasis on enhancement on the safety and efficacy of laparoscopic procedures can be seen on value-based healthcare.

The forecast CAGR of 4.2% indicates a significant fall in the growth rate of the market in comparison to the historical CAGR in the future. The decline in CAGR can be attributed to several factors, including

• The market may be reaching a point of saturation in certain regions or segments due to the boom in adoption of laparoscopic devices, which further results in slower growth rates.
• Healthcare spending and investment in medical equipment are mainly impacted by economic downturns or uncertainties in important markets, leading to slower growth rates than in previous years.

Key Threats Hindering the Laparoscopic Device Market

• Rapid advancements in technology, like emergence of robotic-assisted surgery and alternative minimally invasive techniques, could restrict the demand for traditional laparoscopic devices.
• Intense competition among key players lead to pricing pressures, erosion of profit margins, and challenges in market share retention.
• Reduction in reimbursement rates or restrictions on coverage for laparoscopic surgeries dampen the healthcare providers from investing in laparoscopic devices, affecting market growth.
• High-profile product recalls or safety warnings may lead to defamation of the reputed manufacturers and deter future adoption of their devices, impacting market growth.

Country-wise Insights

The table analyses the top five countries ranked by revenue, with India holding the top position.

Due to robust medical tourism industry, cost-effective yet high-quality healthcare services are offered.

India attracts a significant number of international patients seeking minimally invasive surgical procedures performed using laparoscopic devices.

Forecast CAGRs from 2024 to 2034

Countries	CAGR from 2024 to 2034
The United States	2.6%
Canada	4%
France	3%
Thailand	5.8%
India	6.2%

Minimally Invasive Surgery (MIS) Drive the United States Market

• Minimal invasive surgical procedures, including gynecology, urology, general surgery, and bariatric surgery are taking place where laparoscopic devices are extensively used in the United States.
• Common laparoscopic procedures are performed in the United States include laparoscopic cholecystectomy (gallbladder removal), laparoscopic appendectomy, laparoscopic hysterectomy, and laparoscopic colectomy.

Surgical Specialties Impresses the Market Growth in Canada

• Laparoscopic devices are extensively utilized across a wide range of surgical specialties, like general surgery, urology, gynecology, and gastroenterology.
• Laparoscopic procedures including laparoscopic hernia repair, laparoscopic prostatectomy, laparoscopic ovarian cystectomy, and laparoscopic colorectal surgery are often performed in healthcare facilities in Canada.

Gynecological Surgery Drives the Market in France

• A large percentage of laparoscopic equipment is used for treatments including laparoscopic hysterectomy, myomectomy, and endometriosis therapy as France is recognized for its proficiency in laparoscopic gynecological surgery.
• Laparoscopic techniques are required in gynecological treatments, which are also used for pelvic floor repair, ovarian cystectomy, and tubal ligation.

Thailand Market Boosts Medical Tourism

• Thailand has become a well-liked travel destination for medical tourism, which majorly includes laparoscopic surgery and other minimally invasive surgical treatments.
• International patients travel to the nation for accessing high-quality and reasonably priced healthcare services, including laparoscopic procedures.

Affordable Healthcare Raises the Market Growth in India

• Laparoscopic instruments are important due to the provision of accessible and reasonably priced healthcare facilities in India, especially in tertiary care hospitals and metropolitan areas.
• India comprises of a wide range of patients that receive laparoscopic procedures, including laparoscopic gallbladder removal, laparoscopic hernia repair, laparoscopic hysterectomy, and laparoscopic bariatric surgery.

Category-wise Insights

The below section shows the leading segment. Based on product type, the direct energy system device is accounted to hold a market share of 28.5% in 2024. Based on application, the bariatric surgery segment is accounted to hold a market share of 28% in 2024.

The growth of direct energy system devices is fueled by the ability to provide surgeons which explicitly control over effective tissue sealing and cutting capabilities.

Bariatric surgery is becoming more popular as it provides a practical way in losing weight and addressing comorbidities associated with obesity.

Category	Market Share in 2024
Direct Energy System Device	28.5%
Bariatric Surgery	28%

Direct Energy System Device to Hold a Significant Share in the Market

In 2024, the direct energy system device segment has a market share of 28.5%. The devices play a demanding role in minimally invasive surgeries, which offer precise control and effective tissue sealing and cutting capabilities by the surgeons.

Technological developments and rise in the usage of direct energy system devices by medical facilities have made vital instruments for a variety of surgical procedures, which has highly boosted their market domination.

Bariatric Surgery Segment to Hold a Dominant Share in the Market

The bariatric surgery segment holds a market share of 28% in 2024, reflecting the boost in demand for laparoscopic procedures by addressing obesity-related health concerns. Bariatric surgeries, like gastric bypass and sleeve gastrectomy, lead to utilization of laparoscopic techniques in reducing the size of the stomach by promoting weight loss.

With rise in obesity rates and growth in the awareness of the benefits of minimally invasive approaches, the bariatric surgery segment is anticipated to continue its strong growth trajectory in the coming years.

Competitive Landscape

Innovative companies are disrupting traditional players by introducing novel technologies and approaches in the laparoscopic device market. Startups are ascending advancements in robotics, artificial intelligence, and miniaturization for developing cutting-edge laparoscopic devices offering improved precision, efficiency, and patient outcomes.

Startups hence focus on niche segments or specialize in specific aspects of laparoscopic surgery, like imaging systems, energy devices, or surgical robotics.

Key developments in the laparoscopic device industry

• In February 2023, Asensus Surgical, Inc. announced a Memorandum of Understanding with KARL STORZ VentureONE Pte. Ltd., that focused on endoscopes and laparoscopic vision systems.
• In January 2022, Seger Surgical Solutions developed the LAP IA 60 device for intracorporeal anastomosis. The device efficiently aligned, sealed, and stapled intracorporeal anastomosis openings, which offered a secure and rapid solution without the need for internal fixation.

Key Coverage in the Laparoscopic Device Industry Report

• Adjacent Study on Laparoscopic Device Market, Laparoscopy Instruments Market
• Industry Analysis of Laparoscopy and Endoscopy Devices
• Laparoscopic Device Market Size, Current Insights, and Demographic Trends
• Demand for Laparoscopic Device Market
• Key Strategies in Global Laparoscopic Device Market

Report Scope

Attributes	Details
Estimated Market Size in 2024	USD 13.59 billion
Projected Market Valuation in 2034	USD 20.5 billion
Value-based CAGR 2024 to 2034	4.2%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in USD billion
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East and Africa
Key Market Segments Covered	Product,   Therapeutic Application,   End-user,   Region
Key Countries Profiled	The United States,  Canada,  Brazil,  Mexico,  Germany,  The United Kingdom,  France,  Spain,  Italy,  Russia,  Poland,  Czech Republic,  Romania,  India,  Bangladesh,  Australia,  New Zealand,  China,  Japan,  South Korea,  GCC countries,  South Africa,  Israel
Key Companies Profiled	Olympus Corporation;  B. Braun Melsungen AG;  Intuitive Surgical Inc.;  Medtronic plc.;  Stryker Corporation;  Smith & Nephew Plc;  CareFusion Corporation;  Ethicon US, LLC;  Tekno-Medical Optik Surgery GmbH;  Richard Wolf GmbH;  Endocontrol SA

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
  • 5.1. Direct Energy System Devices
  • 5.2. Trocars/Access Device
  • 5.3. Internal Closure Devices
  • 5.4. Laparoscopes
  • 5.5. Hand Access Instruments
  • 5.6. Insufflation Devices
  • 5.7. Robotic Assisted Surgical System
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapeutic Application
  • 6.1. Bariatric Surgery
  • 6.2. Colorectal Surgery
  • 6.3. General Surgery
  • 6.4. Gynecological Surgery
  • 6.5. Urological Surgery
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 7.1. Hospitals
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 8.1. North America
  • 8.2. Latin America
  • 8.3. Western Europe
  • 8.4. Eastern Europe
  • 8.5. South Asia and Pacific
  • 8.6. East Asia
  • 8.7. Middle East and Africa
• 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 16. Key Countries Market Analysis
• 17. Market Structure Analysis
• 18. Competition Analysis
  • 18.1. Olympus Corporation
  • 18.2. B. Braun Melsungen AG
  • 18.3. Intuitive Surgical Inc.
  • 18.4. Medtronic plc.
  • 18.5. Stryker Corporation
  • 18.6. Smith & Nephew Plc
  • 18.7. CareFusion Corporation
  • 18.8. Ethicon US, LLC
  • 18.9. Tekno-Medical Optik Surgery GmbH
  • 18.10. Richard Wolf GmbH
  • 18.11. Endocontrol SA
• 19. Assumptions & Acronyms Used
• 20. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 4: Global Market Volume (Units) Forecast by Product, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 6: Global Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 7: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 8: Global Market Volume (Units) Forecast by End User, 2019 to 2034

Table 9: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 12: North America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 13: North America Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 14: North America Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 15: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 16: North America Market Volume (Units) Forecast by End User, 2019 to 2034

Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 19: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 20: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 21: Latin America Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 22: Latin America Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 23: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 24: Latin America Market Volume (Units) Forecast by End User, 2019 to 2034

Table 25: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 27: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 28: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 29: Western Europe Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 30: Western Europe Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 31: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 32: Western Europe Market Volume (Units) Forecast by End User, 2019 to 2034

Table 33: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 35: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 36: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 37: Eastern Europe Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 38: Eastern Europe Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 39: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 40: Eastern Europe Market Volume (Units) Forecast by End User, 2019 to 2034

Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034

Table 43: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 44: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034

Table 45: South Asia and Pacific Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 46: South Asia and Pacific Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 47: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 48: South Asia and Pacific Market Volume (Units) Forecast by End User, 2019 to 2034

Table 49: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034

Table 51: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 52: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034

Table 53: East Asia Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 54: East Asia Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 55: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 56: East Asia Market Volume (Units) Forecast by End User, 2019 to 2034

Table 57: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034

Table 59: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 60: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034

Table 61: Middle East and Africa Market Value (US$ Million) Forecast by Therapeutic Application, 2019 to 2034

Table 62: Middle East and Africa Market Volume (Units) Forecast by Therapeutic Application, 2019 to 2034

Table 63: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 64: Middle East and Africa Market Volume (Units) Forecast by End User, 2019 to 2034

List of Figures

Figure 1: Global Market Value (US$ Million) by Product, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by End User, 2024 to 2034

Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 6: Global Market Volume (Units) Analysis by Region, 2019 to 2034

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 9: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 10: Global Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 13: Global Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 14: Global Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 15: Global Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 16: Global Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 17: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 18: Global Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 21: Global Market Attractiveness by Product, 2024 to 2034

Figure 22: Global Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 23: Global Market Attractiveness by End User, 2024 to 2034

Figure 24: Global Market Attractiveness by Region, 2024 to 2034

Figure 25: North America Market Value (US$ Million) by Product, 2024 to 2034

Figure 26: North America Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 27: North America Market Value (US$ Million) by End User, 2024 to 2034

Figure 28: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 29: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 33: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 34: North America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 37: North America Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 38: North America Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 39: North America Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 40: North America Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 41: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 42: North America Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 43: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 44: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 45: North America Market Attractiveness by Product, 2024 to 2034

Figure 46: North America Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 47: North America Market Attractiveness by End User, 2024 to 2034

Figure 48: North America Market Attractiveness by Country, 2024 to 2034

Figure 49: Latin America Market Value (US$ Million) by Product, 2024 to 2034

Figure 50: Latin America Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 51: Latin America Market Value (US$ Million) by End User, 2024 to 2034

Figure 52: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 57: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 58: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 61: Latin America Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 62: Latin America Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 65: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 66: Latin America Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 67: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 69: Latin America Market Attractiveness by Product, 2024 to 2034

Figure 70: Latin America Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 71: Latin America Market Attractiveness by End User, 2024 to 2034

Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 73: Western Europe Market Value (US$ Million) by Product, 2024 to 2034

Figure 74: Western Europe Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 75: Western Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 76: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 77: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 81: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 82: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 85: Western Europe Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 86: Western Europe Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 89: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 90: Western Europe Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 91: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 93: Western Europe Market Attractiveness by Product, 2024 to 2034

Figure 94: Western Europe Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 95: Western Europe Market Attractiveness by End User, 2024 to 2034

Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 97: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034

Figure 98: Eastern Europe Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 99: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 100: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 101: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 105: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 106: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 110: Eastern Europe Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 113: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 114: Eastern Europe Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 117: Eastern Europe Market Attractiveness by Product, 2024 to 2034

Figure 118: Eastern Europe Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 119: Eastern Europe Market Attractiveness by End User, 2024 to 2034

Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 121: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034

Figure 122: South Asia and Pacific Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 123: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034

Figure 124: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 125: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 129: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 133: South Asia and Pacific Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 138: South Asia and Pacific Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 141: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034

Figure 142: South Asia and Pacific Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 143: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034

Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 145: East Asia Market Value (US$ Million) by Product, 2024 to 2034

Figure 146: East Asia Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 147: East Asia Market Value (US$ Million) by End User, 2024 to 2034

Figure 148: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 149: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 153: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 154: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 155: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 157: East Asia Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 158: East Asia Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 159: East Asia Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 161: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 162: East Asia Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 163: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 164: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 165: East Asia Market Attractiveness by Product, 2024 to 2034

Figure 166: East Asia Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 167: East Asia Market Attractiveness by End User, 2024 to 2034

Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 169: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034

Figure 170: Middle East and Africa Market Value (US$ Million) by Therapeutic Application, 2024 to 2034

Figure 171: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034

Figure 172: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 173: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 177: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 178: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Therapeutic Application, 2019 to 2034

Figure 182: Middle East and Africa Market Volume (Units) Analysis by Therapeutic Application, 2019 to 2034

Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Therapeutic Application, 2024 to 2034

Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2024 to 2034

Figure 185: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 186: Middle East and Africa Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 189: Middle East and Africa Market Attractiveness by Product, 2024 to 2034

Figure 190: Middle East and Africa Market Attractiveness by Therapeutic Application, 2024 to 2034

Figure 191: Middle East and Africa Market Attractiveness by End User, 2024 to 2034

Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034